investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Programming T Cell Fates for Therapeutic Use

Luca Gattinoni

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Together with Dr. Zehn's group we are exploring the role of microRNA-155 in CD8+ T cell responses

Related projects

Jon C Aster

Oncogenic Notch Signaling

Leukaemia

Pathology Hematology and hematologic malignancies

James You

Role of MicroRNAs in the Tumorigenesis of T-ALL

Leukaemia

Pathology Hematology and hematologic malignancies

Mitch Mcvey

Mechanisms and consequences of inaccurate DNA double-strand break repair

Leukaemia

Pathology

Scott W Lowe

The impact of chromosome 17p lesions on leukemogeneis and therapy response

Leukaemia

Pathology Hematology and hematologic malignancies

Jeffrey S Miller

Viral priming and targeting NK cells against solid tumor malignancies

Leukaemia

Hematology and hematologic malignancies

Katy Rezvani

Curative Cell-based Therapies for Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Bruce R Blazar

Cytotoxic-T-Lymphocyte (CTL) Therapy of Acute Myeloid Leukemia (AML)

Leukaemia

Pathology Hematology and hematologic malignancies

Thomas Waldmann

IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

Leukaemia

Pathology Hematology and hematologic malignancies

Bruno Calabretta

Targeting the C/EBPalpha-Gfi-pathway in CML stem cells

Leukaemia

Pathology Hematology and hematologic malignancies